ArticleClinical and translational medicine2025

iDICss robustly predicts melanoma immunotherapy response by synergizing genomic and transcriptomic knowledge via independent component analysis.

Jiayue Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.